Delivery Order SPE2DX22D0010-SPE2D826FAQ47
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) under a firm fixed-price contract. The award, made on August 31, 2025, with an ultimate completion date of September 2, 2025, represents a competitive, non-set-aside procurement for pharmaceutical supply to support military healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) on August 24, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 7, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $5,702.74. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award was competitively awarded...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,072.23 for OxyContin tablets (20mg) by the Department of Defense Medical Supply Chain, with an award date of October 5, 2025, and ultimate completion by October 6, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- On September 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,544.19 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units). The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be completed by September 15, 2025, at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of OxyContin tablets 40mg, with a contract ceiling value of $2,508.63 and an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 27, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This firm fixed-price, non-set-aside contract has an ultimate completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements for...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) under a firm fixed-price arrangement valued at $6,007.92, with completion scheduled for July 11, 2025. This non-set-aside award reflects competitive procurement practices and represents a small-value delivery order within the context of AmerisourceBergen's broader federal pharmaceutical supply operations....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 8, 2025, for the supply of OxyContin tablets (20 mg) with a ceiling value of $3,184.28. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to conclude on June 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAQ47Delivery Order
The Defense Department's Medical Supply Chain has awarded a delivery order valued at $5,072.23 to AmerisourceBergen Drug Corp for OxyContin tablets (20 mg), with completion scheduled for October 27, 2025. This firm fixed-price delivery order, awarded on October 26, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains a significant presence within the Defense Logistics Agency's supply chain ecosystem. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 10/26/25 |